Best disease
Jump straight to:
What is Best disease?
What causes Best disease?
How is Best disease inherited?
What are the signs and symptoms of Best disease?
What are the different stages of Best disease?
How is Best disease diagnosed?
What are the treatments for Best disease?
Living with Best disease
Latest research into Best disease?
Back to:
List of Eye Conditions
Last updated September 2026
Approved by Associate Professor Amanda Carr, UCL Institute of Ophthalmology.
Amanda is an associate professor and principal investigator at the UCL Institute of Ophthalmology, where she uses stem cells to advance vision research.
What is Best disease?
Best disease (also known as vitelliform macular dystrophy, Best’s disease, or Best eye disease) is an inherited condition that causes progressive sight loss. The word ‘vitelliform’ means ‘shaped like an egg yolk. In early stages, yellow material (lipofuscin) accumulates in an egg-like shape beneath the centre of the retina, also known as the macula, damaging it over time.
The age of onset for Best disease typically varies, but it is usually diagnosed from early childhood to teenage age. Approximately 1 in 10,000 people in the UK have vision loss caused by Best disease.
What causes Best disease?
Best disease is caused by mutations in a gene called BEST1, which provides instructions for producing a protein that is responsible for transporting key molecules in and out of the retina. Mutation in this gene leads to production of a faulty BEST1 protein instead of a regularly functioning one, resulting in the build-up of a lipofuscin lesion beneath the macula.
How is Best disease inherited?
Best disease can be caused by a variety of mutations. The majority of mutations are ‘autosomal dominant’. This means, even though each person has two copies of the BEST1 gene inherited from each parent, inheriting a mutation in one of them is enough to cause the condition.
In some instances patients can inherit two faulty copies of the gene, meaning a child must inherit both faulty BEST1 copies for the condition to manifest.
What are the signs and symptoms of Best disease?
Due to the numerous mutations that can cause Best disease, signs and symptoms may vary. Symptoms can start from the age of three, or earlier and slowly become worse over time.
Typical symptoms of Best disease include:
Loss of central vision: The macula is located in the retinal centre, so degeneration in this region mainly affects central vision.
Reduced ability to perceive colours and details: The photoreceptors perceiving colour (cones) are located in the macula, meaning macular damage affects colour vision considerably.
Different levels of vision loss in each eye: Lipofuscin build-up and/or degradation levels caused by it may be different in either eye.
Seeing things that appear oddly shaped: The lesion can displace the retina by ‘pushing’ it out of its original position, causing distortion in vision.
Severe vision loss: If Best disease progresses to severe stages, it can cause severe vision loss.
What are the different stages of Best eye disease?
Best disease can progress in various stages, where further progression typically results in more damage and hence more severe symptoms. Not everyone will progress through all of them.
Previtelliform stage: The lipofuscin lesion hasn’t yet developed. Symptoms are typically absent at this stage.
Vitelliform stage: The characteristic lipofuscin lesion has developed, shaped like an ‘egg-yolk’ in the macula. The disease is most easily identified at this stage. This may result in mild vision loss.
Pseudohypopyon stage: Lipofuscin has begun layering in the macula. Vision remains similar to the Vitelliform stage.
Vitelleruptive stage: Lipofuscin has begun to break up, giving a ‘scrambled-egg’ like appearance. Yellow deposits might also build-up at the back of the eye. Vision may or may not decrease from the previous stage.
Atrophic stage: The macula and/or the retinal cell layer has begun to degenerate (atrophy), causing the main symptoms associated with the disease (i.e. central vision loss). When the condition progresses to this stage, vision is typically 20/30 - 20/300.
Choroidal neovascularisation: Only about 20% of people with Best disease will progress to this stage. New blood vessels are formed under the retina, which may leak and worsen vision further, often up to 20/200 or poorer.
As Best disease only affects central vision those with the disease will not go completely blind.
How is Best disease diagnosed?
Best disease is often diagnosed during childhood or adolescence. After verification of medical history and an eye exam, further tests that may be used to confirm a clinical diagnosis are as follows:
Ophthalmoscopy: A simple eye exam that uses light and magnification to view the back wall of the eye. This is the main way patients are initially identified - identification of vitelliorm lesion
Electro-oculogram (EOG): Measures the state of the retina by checking for abnormal retinal membrane potential.
Optical coherence tomography (OCT): An imaging technique that uses light waves to take a cross-section picture of the retina.
Fluorescein angiography (FA): An imaging technique using dyes that shows the state of blood vessels in the retina.
Genetic testing: To check that the BEST1 gene is mutated.
Stay in the loop
on eye research breakthroughs, inspiring real life stories and more...
What are the treatments for Best disease?
While there is no cure for Best disease yet, there are methods and treatments to help manage symptoms and prevent disease progression, especially to the final stage involving growth of new blood vessels in the retina.
Anti-vascular endothelial growth factor (Anti-VEGF) therapy, which involves injecting medication directly into the eye to prevent abnormal vessel growth, has shown such potential in patients with neovascular complications.
Additionally, laser or photodynamic therapy may be used to help close the blood vessels and prevent leakage.
Treatment involving the use of induced pluripotent stem cells (cells that can differentiate into nearly any cell type in the body) to replace degenerated retinal cells is currently under intense research and is being considered as a future therapeutic strategy.
Evidence has shown gene therapy targeting BEST1 may be beneficial, but clinical trials for this type of treatment are still under investigation.
Living with Best disease?
Being diagnosed with Best disease can be daunting and overwhelming at first. Therefore, it is reassuring to know that people with Best disease are still able to live independently through both visual aids and clinical support.
After initial diagnosis, regular eye appointments are typically scheduled to ensure any changes in the condition can be found and managed early.
If the disease manifests at a young age, there are qualified teachers specialising in helping children with visual impairment at school. Children can also be registered as sight-impaired for access to social support.
At adulthood, patients are typically still able to perform day-to-day activities, and for most people, Best disease does not reduce vision to the point where they cannot drive.
Bioptic lenses or miscellaneous vision enhancement glasses might be used to help with activities that require good central vision such as reading, studying, or computer work.
What research is there into Best disease?
Research into Best disease continues to show us more about the effects of different faults in the BEST1 gene. Finding out how the mutations lead to the ‘common denominator’ symptom of lipofuscin build-up could be key to understanding the various functions of the Best proteins encoded by the genes and hence can help design drugs with specific targets in mind.
Fight for Sight has funded several research projects evaluating the effectiveness of treatments such as gene and stem cell therapy.
Professor Robert MacLaren was awarded a grant for gene therapy development for Best disease, which could also have significant potential to treat many inherited eye conditions. The Best1 protein is located in the ‘retinal pigment epithelium’ (RPE) part of the eye, a layer of cells that support the retina. Professor MacLaren and his team showed that a modified virus could be used to deliver a working copy of the BEST1 gene to RPE cells [in mice], restoring production of the Bestotrophin-1 protein, which is needed for healthy vision.
This research is an important step towards a gene therapy for autosomal recessive bestrophinopathy, and could help pave the way for new gene therapies for other inherited retinal conditions caused by changes in the BEST1 gene.
Professor Rachel Pearson’s team looked into replacing damaged retinal cells as a form of therapy for Best disease. Normally, scar tissue makes it difficult for new cells to move into position to replace damaged ones. They looked into the factors affecting retinal cell transplant success. A better understanding of it would help establish steps needed to effectively implement cell replacement therapy as treatment.
Change is in sight but we need your help to bring it closer.
If you're personally affected by Best disease and are interested in fundraising to help us fund cutting-edge research in this area, find out how to set up a family fund.
-
Understanding
-
Diagnosis
-
Treatment
-
Our research
- Understanding
- Diagnosis
- Treatment
- Our research